Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Valve Type and Anesthesia Strategy for TAVR: 5-Year Results of the SOLVE-TAVI Trial.
Feistritzer HJ, Kurz T, Vonthein R, Schröder L, Stachel G, Eitel I, Marquetand C, Saraei R, Kirchhof E, Heringlake M, Abdel-Wahab M, Desch S, Thiele H; SOLVE-TAVI Investigators. Feistritzer HJ, et al. Among authors: kurz t. J Am Coll Cardiol. 2025 Jan 7;85(1):74-82. doi: 10.1016/j.jacc.2024.09.007. Epub 2024 Nov 6. J Am Coll Cardiol. 2025. PMID: 39503651 Clinical Trial.
Fractal dimension of the aortic annulus: a novel predictor of paravalvular leak after transcatheter aortic valve implantation.
Stachel G, Abdel-Wahab M, de Waha-Thiele S, Desch S, Feistritzer HJ, Kitamura M, Farhan S, Eitel I, Kurz T, Thiele H. Stachel G, et al. Among authors: kurz t. Int J Cardiovasc Imaging. 2022 Nov;38(11):2469-2478. doi: 10.1007/s10554-022-02657-1. Epub 2022 Jun 24. Int J Cardiovasc Imaging. 2022. PMID: 36434335 Free PMC article. Clinical Trial.
Glycoprotein IIb/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial.
Eitel I, Saraei R, Jurczyk D, Fach A, Hambrecht R, Wienbergen H, Frerker C, Schmidt T, Allali A, Joost A, Marquetand C, Kurz T, Haaf P, Fahrni G, Mueller C, Desch S, Thiele H, Stiermaier T. Eitel I, et al. Among authors: kurz t. Eur Heart J. 2024 Dec 16;45(47):5058-5067. doi: 10.1093/eurheartj/ehae587. Eur Heart J. 2024. PMID: 39217605 Clinical Trial.
Expanding the Chemical Space of Reverse Fosmidomycin Analogs.
Knak T, Takada S, Illarionov B, Krisilia V, Pessanha de Carvalho L, Lungerich B, Sakamoto Y, Höfmann S, Bacher A, Kalscheuer R, Held J, Fischer M, Tanaka N, Kurz T. Knak T, et al. Among authors: kurz t. ACS Med Chem Lett. 2024 Dec 23;16(1):136-143. doi: 10.1021/acsmedchemlett.4c00501. eCollection 2025 Jan 9. ACS Med Chem Lett. 2024. PMID: 39811140
The Diverse Binding Modes Explain the Nanomolar Levels of Inhibitory Activities Against 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase from Plasmodium falciparum Exhibited by Reverse Hydroxamate Analogs of Fosmidomycin with Varying N-Substituents.
Takada S, Abdullaziz MA, Höfmann S, Knak T, Ozawa SI, Sakamoto Y, Kurz T, Tanaka N. Takada S, et al. Among authors: kurz t. Molecules. 2024 Dec 28;30(1):72. doi: 10.3390/molecules30010072. Molecules. 2024. PMID: 39795129 Free PMC article.
TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance.
Knaab TC, Moritz A, Pessanha de Carvalho L, Klein S, Lungerich B, Lohse K, Kruse L, Mombo-Ngoma G, Orta L, Thibaud JL, de Villiers KA, Fidock DA, Burckhardt BB, Held J, Wittlin S, Kurz T. Knaab TC, et al. Among authors: kurz t. J Med Chem. 2025 Jan 9;68(1):95-107. doi: 10.1021/acs.jmedchem.4c01465. Epub 2024 Dec 26. J Med Chem. 2025. PMID: 39723908
Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.
Fischer F, Schliehe-Diecks J, Tu JW, Gangnus T, Ho YL, Hebeis M, Alves Avelar LA, Scharov K, Watrin T, Kemkes M, Stachura P, Daugs K, Biermann L, Kremeyer J, Horstick N, Span I, Pandyra AA, Borkhardt A, Gohlke H, Kassack MU, Burckhardt BB, Bhatia S, Kurz T. Fischer F, et al. Among authors: kurz t. J Med Chem. 2024 Dec 12;67(23):21223-21250. doi: 10.1021/acs.jmedchem.4c02024. Epub 2024 Nov 27. J Med Chem. 2024. PMID: 39602240
A focus shift in the evaluation of misinformation interventions.
Tay LQ, Lewandowsky S, Hurlstone MJ, Kurz T, Ecker UKH. Tay LQ, et al. Among authors: kurz t. Harv Kennedy Sch Misinformation Rev. 2023 Oct;4(5):mr-2020-124. doi: 10.37016/mr-2020-124. Epub 2023 Oct 5. Harv Kennedy Sch Misinformation Rev. 2023. PMID: 39301480 Free PMC article.
311 results